Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Proc (Bayl Univ Med Cent) ; 31(3): 362-363, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29904313

ABSTRACT

Malignant tumors composed of both epithelial and melanocytic populations are exceedingly rare. Because the etiology of these malignant tumors is not yet defined, several authors have argued for the continued cataloging of these lesions. We present a 67-year-old man with a suspicious-appearing lesion on the right forearm; initial biopsy was consistent with a pigmented basal cell carcinoma. On re-excision, a collision of malignant melanoma and basal cell was identified.

2.
Pediatr Dermatol ; 35(4): 482-485, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29600537

ABSTRACT

Hyper-immunoglobulin D syndrome is a rare autosomal-recessive autoinflammatory syndrome in which a mevalonate kinase deficiency results due to mutations of the mevalonate kinase gene. We report a case of an Asian male infant who was found to have hyper-immunoglobulin D syndrome in the absence of fever. His skin manifestations included cephalic pustulosis as well recurrent transient and fixed pink plaques and nodules on the face and extremities. Subsequent examination revealed hyper-immunoglobulin D syndrome with two novel allelic mutations in the mevalonate kinase gene: c.895G > A (p.D299N) and c.1168C > T (p.Q390). It is important for dermatologists to recognize the varied cutaneous presentations of hyper-immunoglobulin D syndrome because rapid diagnosis and treatment can significantly affect outcomes.


Subject(s)
Mevalonate Kinase Deficiency/diagnosis , Phosphotransferases (Alcohol Group Acceptor)/genetics , Antirheumatic Agents/therapeutic use , Humans , Immunoglobulin D/blood , Infant , Interleukin 1 Receptor Antagonist Protein/therapeutic use , Male , Mutation , Skin/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...